194 related articles for article (PubMed ID: 8197111)
1. Cellular transformation by a transmembrane peptide: structural requirements for the bovine papillomavirus E5 oncoprotein.
Meyer AN; Xu YF; Webster MK; Smith AE; Donoghue DJ
Proc Natl Acad Sci U S A; 1994 May; 91(11):4634-8. PubMed ID: 8197111
[TBL] [Abstract][Full Text] [Related]
2. Role of glutamine 17 of the bovine papillomavirus E5 protein in platelet-derived growth factor beta receptor activation and cell transformation.
Klein O; Polack GW; Surti T; Kegler-Ebo D; Smith SO; DiMaio D
J Virol; 1998 Nov; 72(11):8921-32. PubMed ID: 9765437
[TBL] [Abstract][Full Text] [Related]
3. Identification of amino acids in the transmembrane and juxtamembrane domains of the platelet-derived growth factor receptor required for productive interaction with the bovine papillomavirus E5 protein.
Petti LM; Reddy V; Smith SO; DiMaio D
J Virol; 1997 Oct; 71(10):7318-27. PubMed ID: 9311809
[TBL] [Abstract][Full Text] [Related]
4. The bovine papillomavirus E5 protein and the PDGF beta receptor: it takes two to tango.
Talbert-Slagle K; DiMaio D
Virology; 2009 Feb; 384(2):345-51. PubMed ID: 18990418
[TBL] [Abstract][Full Text] [Related]
5. Transformation-specific interaction of the bovine papillomavirus E5 oncoprotein with the platelet-derived growth factor receptor transmembrane domain and the epidermal growth factor receptor cytoplasmic domain.
Cohen BD; Goldstein DJ; Rutledge L; Vass WC; Lowy DR; Schlegel R; Schiller JT
J Virol; 1993 Sep; 67(9):5303-11. PubMed ID: 8394451
[TBL] [Abstract][Full Text] [Related]
6. The transmembrane domain of the E5 oncoprotein contains functionally discrete helical faces.
Adduci AJ; Schlegel R
J Biol Chem; 1999 Apr; 274(15):10249-58. PubMed ID: 10187811
[TBL] [Abstract][Full Text] [Related]
7. Mutational analysis of the interaction between the bovine papillomavirus E5 transforming protein and the endogenous beta receptor for platelet-derived growth factor in mouse C127 cells.
Nilson LA; Gottlieb RL; Polack GW; DiMaio D
J Virol; 1995 Sep; 69(9):5869-74. PubMed ID: 7543592
[TBL] [Abstract][Full Text] [Related]
8. E5 oncoprotein transmembrane mutants dissociate fibroblast transforming activity from 16-kilodalton protein binding and platelet-derived growth factor receptor binding and phosphorylation.
Sparkowski J; Mense M; Anders J; Schlegel R
J Virol; 1996 Apr; 70(4):2420-30. PubMed ID: 8642670
[TBL] [Abstract][Full Text] [Related]
9. Multiple transmembrane amino acid requirements suggest a highly specific interaction between the bovine papillomavirus E5 oncoprotein and the platelet-derived growth factor beta receptor.
Nappi VM; Petti LM
J Virol; 2002 Aug; 76(16):7976-86. PubMed ID: 12134002
[TBL] [Abstract][Full Text] [Related]
10. Mutational analysis of the beta-type platelet-derived growth factor receptor defines the site of interaction with the bovine papillomavirus type 1 E5 transforming protein.
Staebler A; Pierce JH; Brazinski S; Heidaran MA; Li W; Schlegel R; Goldstein DJ
J Virol; 1995 Oct; 69(10):6507-17. PubMed ID: 7666552
[TBL] [Abstract][Full Text] [Related]
11. Alanine mutagenesis of conserved residues in the platelet-derived growth factor family: identification of residues necessary for dimerization and transformation.
Maher DW; Strawn LM; Donoghue DJ
Oncogene; 1993 Mar; 8(3):533-41. PubMed ID: 8437840
[TBL] [Abstract][Full Text] [Related]
12. The bovine papillomavirus E5 protein requires a juxtamembrane negative charge for activation of the platelet-derived growth factor beta receptor and transformation of C127 cells.
Klein O; Kegler-Ebo D; Su J; Smith S; DiMaio D
J Virol; 1999 Apr; 73(4):3264-72. PubMed ID: 10074180
[TBL] [Abstract][Full Text] [Related]
13. The v-sis protein retains biological activity as a type II membrane protein when anchored by various signal-anchor domains, including the hydrophobic domain of the bovine papilloma virus E5 oncoprotein.
Xu YF; Meyer AN; Webster MK; Lee BA; Donoghue DJ
J Cell Biol; 1993 Nov; 123(3):549-60. PubMed ID: 8227125
[TBL] [Abstract][Full Text] [Related]
14. Ligand-independent activation of the platelet-derived growth factor beta receptor: requirements for bovine papillomavirus E5-induced mitogenic signaling.
Drummond-Barbosa D; Vaillancourt RR; Kazlauskas A; DiMaio D
Mol Cell Biol; 1995 May; 15(5):2570-81. PubMed ID: 7739538
[TBL] [Abstract][Full Text] [Related]
15. Stable association between the bovine papillomavirus E5 transforming protein and activated platelet-derived growth factor receptor in transformed mouse cells.
Petti L; DiMaio D
Proc Natl Acad Sci U S A; 1992 Aug; 89(15):6736-40. PubMed ID: 1323117
[TBL] [Abstract][Full Text] [Related]
16. A single amino acid substitution converts a transmembrane protein activator of the platelet-derived growth factor β receptor into an inhibitor.
Petti LM; Talbert-Slagle K; Hochstrasser ML; DiMaio D
J Biol Chem; 2013 Sep; 288(38):27273-27286. PubMed ID: 23908351
[TBL] [Abstract][Full Text] [Related]
17. Two transmembrane dimers of the bovine papillomavirus E5 oncoprotein clamp the PDGF β receptor in an active dimeric conformation.
Karabadzhak AG; Petti LM; Barrera FN; Edwards APB; Moya-Rodríguez A; Polikanov YS; Freites JA; Tobias DJ; Engelman DM; DiMaio D
Proc Natl Acad Sci U S A; 2017 Aug; 114(35):E7262-E7271. PubMed ID: 28808001
[TBL] [Abstract][Full Text] [Related]
18. Towards a structural understanding of the smallest known oncoprotein: investigation of the bovine papillomavirus E5 protein using solution-state NMR.
King G; Oates J; Patel D; van den Berg HA; Dixon AM
Biochim Biophys Acta; 2011 Jun; 1808(6):1493-501. PubMed ID: 21073859
[TBL] [Abstract][Full Text] [Related]
19. Compensatory mutants of the bovine papillomavirus E5 protein and the platelet-derived growth factor β receptor reveal a complex direct transmembrane interaction.
Edwards AP; Xie Y; Bowers L; DiMaio D
J Virol; 2013 Oct; 87(20):10936-45. PubMed ID: 23926343
[TBL] [Abstract][Full Text] [Related]
20. Artificial transmembrane oncoproteins smaller than the bovine papillomavirus E5 protein redefine sequence requirements for activation of the platelet-derived growth factor beta receptor.
Talbert-Slagle K; Marlatt S; Barrera FN; Khurana E; Oates J; Gerstein M; Engelman DM; Dixon AM; Dimaio D
J Virol; 2009 Oct; 83(19):9773-85. PubMed ID: 19605488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]